Efficient iron chelation resulting in improved myocardial performance with combined desferrioxamine and deferiprone in beta thalassemia major patients.

被引:2
|
作者
Pathare, AV [1 ]
Daar, S [1 ]
Al Kindi, S [1 ]
Dennison, JD [1 ]
机构
[1] Sultan Qaboos Univ Hosp, Dept Hematol, Muscat, Oman
关键词
D O I
10.1182/blood.V104.11.3766.3766
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3766
引用
收藏
页码:28B / 28B
页数:1
相关论文
共 50 条
  • [31] EFFECT OF COMBINED CHELATION THERAPY WITH DEFERIPRONE AND DEFEROXAMINE ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN ADULT β-THALASSEMIA MAJOR PATIENTS
    Tsiapras, Dimitrios
    Fragatou, Soso
    Farmaki, Kalistheni
    Kyrzopoulos, Stamatios
    Paraskevaidis, Ioannis
    Voudris, Vasilios
    Kremastinos, Dimitrios
    HEMOGLOBIN, 2010, 34 (03) : 210 - 220
  • [32] A T2*MRI Prospective Survey on Pancreatic Iron in Thalassemia Major Patients Treated with Deferasirox, Deferiprone and Desferrioxamine
    Meloni, Antonella
    Paci, Cristina
    Serra, Giuseppe
    Vacquer, Stefania
    Giugno, Roberto
    Maggio, Aurelio
    Macchi, Silvia
    Neri, Maria Giovanna
    Positano, Vincenzo
    Toia, Patrizia
    Restaino, Gennaro
    Missere, Massimiliano
    Salvatori, Cristina
    Pepe, Alessia
    BLOOD, 2014, 124 (21)
  • [33] A MRI prospective survey on heart iron and function in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
    Pepe, A.
    Meloni, A.
    Rossi, G.
    Natale, L.
    Valeri, G.
    Salvatori, C.
    Keilberg, P.
    Positano, V.
    Maggio, A.
    Lombardi, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 965 - 965
  • [34] Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
    Gillian C Smith
    Francisco Alpendurada
    John Paul Carpenter
    Mohammed H Alam
    Vasili Berdoukas
    Markissia Karagiorga
    Vasili Ladis
    Antonio Piga
    Athanassios Aessopos
    Efstathios D Gotsis
    Mark A Tanner
    Mark A Westwood
    Renzo Galanello
    Michael Roughton
    Dudley J Pennell
    Journal of Cardiovascular Magnetic Resonance, 13
  • [35] Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
    Smith, Gillian C.
    Alpendurada, Francisco
    Carpenter, John Paul
    Alam, Mohammed H.
    Berdoukas, Vasili
    Karagiorga, Markissia
    Ladis, Vasili
    Piga, Antonio
    Aessopos, Athanassios
    Gotsis, Efstathios D.
    Tanner, Mark A.
    Westwood, Mark A.
    Galanello, Renzo
    Roughton, Michael
    Pennell, Dudley J.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2011, 13
  • [36] Combination of Oral Deferiprone and Subcutaneous Infusion of Desferrioxamine in Chelating Overloaded Iron in Pediatric Patients with Beta-Thalassemia Disease
    Chuansumrit, Ampaiwan
    Sirachainan, Norignuch
    Wanichkul, Suthep
    Songdej, Duantida
    Wongwerawattanakoon, Pakawan
    Kadegasem, Praguywan
    BLOOD, 2009, 114 (22) : 1556 - 1556
  • [37] A Cost-Utility Analysis of Deferiprone Compared to Desferrioxamine and Deferasirox for the Treatment of Chronic Myocardial Iron Overload in Thalassemia Patients
    Pepe, Alessia
    Hanif, Aishah
    Bentley, Anthony
    Walker, Roderick
    Frizziero, Ludovica
    Putti, Maria Caterina
    Spasiano, Anna
    Borgna-Pignatti, Caterina
    Maggio, Aurelio
    Neri, Maria Giovanna
    Meloni, Antonella
    BLOOD, 2015, 126 (23)
  • [38] EVALUATION OF IRON CHELATION THERAPY IN BETA THALASSEMIA MAJOR PATIENTS IN EAST DELTA OF EGYPT
    Badr, M.
    Hesham, M.
    Hassan, T.
    Badawy, S. M.
    PEDIATRIC RESEARCH, 2010, 68 : 423 - 424
  • [39] Iron chelation therapy needed for serum ferritin overloaded patients of beta thalassemia major
    Muhammad, Wasim
    Ishaq, Muhammad
    Khan, Muhammad J.
    Ahmad, Umair
    Waseem, Muhammad
    THALASSEMIA REPORTS, 2021, 11 (01)
  • [40] Cardioprotection by deferiprone[L1] inspite of rising serum ferritin in beta thalassemia major patients.
    Pathare, A
    Daar, S
    Alkindi, S
    Dennison, JD
    BLOOD, 2005, 106 (11) : 33B - 33B